AI Assistant
Blog
Pricing
Log In
Sign Up
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
